Kelly Chu

Kelly Chu has been leading technology initiatives in healthcare and other high-profile industries for more than 20 years. He is co-founder and CEO/CTO of Sierra Labs, a biotechnology company that automates compliance in regulated markets. Previously, he led the technology team at Science 37, a company focused on clinical research to rapidly accelerate biomedical discovery and bring down the cost of clinical trials. He is on the board of directors of ScaleLA, an organization that connects global health start-ups, strategic partners, and communities; and ISBX, a web and mobile application development company.